ASK REDCHAT ANYTHING ABOUT IMMUNIC INC.
Immunic Inc. (NASDAQ: IMUX)
Listen to this Section
$12.88
-1.5500
(
-10.70% )
208.4K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Vidofludimus calcium (IMU-838)DetailsMultiple sclerosis, Autoimmune disease |
Phase 2 |
| Vidofludimus calcium (IMU-838)DetailsBowel disorder, Inflammatory bowel disease, Ulcerative colitis |
Phase 2b |
| IMU-856DetailsCeliac disease |
Phase 2b |
| Vidofludimus calcium (IMU-838)DetailsCOVID-19, Infectious disease |
Phase 2 |
| Vidofludimus calcium (IMU-838)DetailsPrimary sclerosing cholangitis, Bile duct disease, Liver disease |
Failed |
| Izumerogant (IMU-935)DetailsPsoriasis |
Failed |
Market Data
|
| Open |
$12.88 |
| Previous Close |
$14.43 |
| Volume |
208.4K |
| Market Cap |
$193.02M |
| Day Range |
$12.76 - $14.77 |
| 52 Week Range |
$5.06 - $15.77 |
| Shares Outstanding |
13.62M |
| Change % |
-10.70% |
| Net Change |
▼ -1.5500 |
| Insider Ownership |
-0.18% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2014 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-3,093,804.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-12 |
Sale |
-100000.00 |
Neermann Joerg |
| 2024-06-12 |
Sale |
-100000.00 |
PHILLIPS BARCLAY A |
| 2024-06-12 |
Sale |
-100000.00 |
Rudick Richard Alan |
| 2024-06-12 |
Sale |
-100000.00 |
HOWSON TAMAR D |
| 2024-03-06 |
Sale |
-29959.00 |
Neermann Joerg |
| 2024-03-06 |
Sale |
-19973.00 |
HOWSON TAMAR D |
| 2024-03-06 |
Sale |
-9986.00 |
Nash Duane |
| 2024-03-06 |
Sale |
-30000.00 |
Toernsen Monika Maria |
| 2024-03-06 |
Sale |
-65000.00 |
Vitt Daniel |
| 2024-03-06 |
Sale |
-100000.00 |
Muehler Andreas |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
3 |
Nov 14, 2025 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| 10-q |
Quarterly Reports |
95 |
Nov 13, 2025 |
| 8-k |
8K-related |
14 |
Nov 13, 2025 |
| 8-k |
8K-related |
28 |
Sep 25, 2025 |
| 8-k |
8K-related |
87 |
Aug 07, 2025 |
| 10-q |
Quarterly Reports |
94 |
Aug 07, 2025 |
| 4 |
Insider transactions |
1 |
Jul 18, 2025 |
| 4 |
Insider transactions |
1 |
Jul 18, 2025 |
| 4 |
Insider transactions |
1 |
Jul 18, 2025 |